Illumina Announces Companion Diagnostic For Amgen Colorectal Cancer Drug

June 30, 2017 | Illumina has announced FDA approval of its Extended RAS Panel for use on the MiSeqDx System. The next-generation sequencing kit is intended to help clinicians identify which patients are eligible for treatment of metastatic colorectal cancer with Amgen's Vectibix. Diagnostics World News